Incyte (INCY) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free INCY Stock Alerts $57.25 -0.06 (-0.10%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 5:58 PM | msn.comIncyte Expands Delaware Presence with New Wilmington BuildingsMay 28 at 4:45 AM | marketbeat.comDimensional Fund Advisors LP Boosts Holdings in Incyte Co. (NASDAQ:INCY)Dimensional Fund Advisors LP lifted its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 7.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 950,626 shares of the biopharmaceutical company's stock after purchaMay 27 at 6:24 PM | marketbeat.comAlta Wealth Advisors LLC Purchases Shares of 16,448 Incyte Co. (NASDAQ:INCY)Alta Wealth Advisors LLC acquired a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 16,448 shares of the biopharmaceutical company's stock, valued at approximately $1,033,000. A numberMay 26 at 4:06 PM | marketbeat.comIntech Investment Management LLC Sells 40,728 Shares of Incyte Co. (NASDAQ:INCY)Intech Investment Management LLC lowered its position in Incyte Co. (NASDAQ:INCY - Free Report) by 31.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 87,678 shares of the biopharmMay 24, 2024 | marketbeat.comOntario Teachers Pension Plan Board Lowers Stake in Incyte Co. (NASDAQ:INCY)Ontario Teachers Pension Plan Board lessened its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 52.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,176 shares of the biopharmaceutical company's stock after selling 29,614 shareMay 24, 2024 | americanbankingnews.comDeutsche Bank Aktiengesellschaft Initiates Coverage on Incyte (NASDAQ:INCY)May 23, 2024 | msn.comIncyte Moving 300 Chadds Ford Jobs to Wilmington in ExpansionMay 23, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Incyte (INCY)May 23, 2024 | markets.businessinsider.com9 Analysts Have This To Say About IncyteMay 23, 2024 | marketbeat.comIncyte (NASDAQ:INCY) Now Covered by Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft began coverage on Incyte in a research report on Thursday. They set a "hold" rating and a $55.00 price objective for the company.May 22, 2024 | msn.comBiotech firm Incyte is moving 400 workers from Pennsylvania to WilmingtonMay 21, 2024 | bizjournals.comIncyte buys 2 buildings in downtown Wilmington for major expansion, moving 300 jobs from Chadds FordMay 21, 2024 | businesswire.comIncyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office BuildingsMay 21, 2024 | marketbeat.comIncyte Q1 Earnings TranscriptMay 21, 2024 | marketbeat.comGreat Lakes Advisors LLC Purchases Shares of 32,382 Incyte Co. (NASDAQ:INCY)Great Lakes Advisors LLC purchased a new stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 32,382 shares of the biopharmaceutical company's stock,May 20, 2024 | marketbeat.comIncyte Co. (NASDAQ:INCY) Shares Acquired by Trexquant Investment LPTrexquant Investment LP increased its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 82.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 295,414 shares of the biopharmaceMay 18, 2024 | marketbeat.comIncyte Co. (NASDAQ:INCY) Holdings Decreased by Robeco Institutional Asset Management B.V.Robeco Institutional Asset Management B.V. trimmed its position in Incyte Co. (NASDAQ:INCY - Free Report) by 32.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 586,653 shares of the biopharmaceutical company's stock afterMay 16, 2024 | markets.businessinsider.comIncyte’s Strategic Moves Amid Share Buyback and Pipeline Expansion: A Balanced Hold RatingMay 15, 2024 | msn.comIncyte’s stock rallies 9% after company says to buy back $1.67 billion of its own stock in Dutch auction tenderMay 15, 2024 | marketbeat.comIncyte (NASDAQ:INCY) Sees Large Volume IncreaseIncyte (NASDAQ:INCY) Sees Strong Trading VolumeMay 15, 2024 | wsj.comStocks to Watch Monday: GameStop, AMC, Squarespace, IncyteMay 15, 2024 | forbes.comHow Does Incyte Stock’s Decline During The 2022 Inflation Shock Compare With The 2008 Crash?May 15, 2024 | marketbeat.comBNP Paribas Financial Markets Acquires 26,818 Shares of Incyte Co. (NASDAQ:INCY)BNP Paribas Financial Markets boosted its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 9.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 304,258 shares of the biopharmaceutical compMay 14, 2024 | businesswire.comIncyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 CongressMay 14, 2024 | finance.yahoo.comCompany News For May 14, 2024May 14, 2024 | marketbeat.comIncyte Co. (NASDAQ:INCY) Shares Sold by Moran Wealth Management LLCMoran Wealth Management LLC trimmed its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 44.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 71,451 shares of the biopharmaceutical companyMay 14, 2024 | marketwatch.comStock Market Today: Dow snaps 8-day winnning streakMay 14, 2024 | finance.yahoo.comHeard on the Street Monday Recap: Hello KittyMay 14, 2024 | benzinga.comGameStop, Squarespace, Incyte And Other Big Stocks Moving Higher On MondayMay 14, 2024 | marketwatch.comIncyte Shares Rally on $2 Billion Buyback PlansMay 14, 2024 | msn.comIncyte Stock Marks Biggest Jump in 7 Years on ‘Dutch Auction’ Buyback Plan. How It Works.May 13, 2024 | marketwatch.comStock Market Today: Dow trades higher as S&P 500 nudges toward record territoryMay 13, 2024 | investopedia.comS&P 500 Gains and Losses Today: Incyte Stock Pops on Buyback PlanMay 13, 2024 | marketbeat.comIncyte (NASDAQ:INCY) Shares Gap Up to $53.06Incyte (NASDAQ:INCY) Shares Gap Up to $53.06May 13, 2024 | marketbeat.comQsemble Capital Management LP Cuts Holdings in Incyte Co. (NASDAQ:INCY)Qsemble Capital Management LP cut its holdings in Incyte Co. (NASDAQ:INCY - Free Report) by 88.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,739 shares of the biopharmaMay 13, 2024 | marketwatch.comIncyte Sets $2 Billion Stock BuybackMay 13, 2024 | msn.comIncyte to buy back $1.67 billion of its own stock in Dutch auction tenderMay 13, 2024 | businesswire.comIncyte Announces Intention to Buy Back up to $2.0 Billion of its Common StockMay 12, 2024 | marketbeat.comJump Financial LLC Increases Stock Holdings in Incyte Co. (NASDAQ:INCY)Jump Financial LLC raised its position in Incyte Co. (NASDAQ:INCY - Free Report) by 1,562.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 99,448 shares of the biopharmaceutical companyMay 9, 2024 | investorplace.comThe 3 Best Biotech Stocks to Buy in May 2024May 8, 2024 | marketbeat.comSwiss National Bank Lowers Holdings in Incyte Co. (NASDAQ:INCY)Swiss National Bank trimmed its position in Incyte Co. (NASDAQ:INCY - Free Report) by 2.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 595,600 shares of the biopharmaceutical company's stock after selling 14,400 shares duriMay 4, 2024 | finance.yahoo.comIncyte First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 4, 2024 | marketbeat.comLSV Asset Management Acquires 1,465,792 Shares of Incyte Co. (NASDAQ:INCY)LSV Asset Management lifted its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 119.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,691,827 shares of the biopharmaceutical company's stock after purchasing an additional 1,465,792 sharMay 3, 2024 | marketbeat.comAnalysts Set Expectations for Incyte Co.'s Q2 2024 Earnings (NASDAQ:INCY)Incyte Co. (NASDAQ:INCY - Free Report) - Investment analysts at William Blair decreased their Q2 2024 earnings per share (EPS) estimates for shares of Incyte in a report issued on Tuesday, April 30th. William Blair analyst M. Phipps now expects that the biopharmaceutical company will post earningMay 3, 2024 | marketbeat.comVan ECK Associates Corp Sells 37,941 Shares of Incyte Co. (NASDAQ:INCY)Van ECK Associates Corp trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 19.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 156,540 shares of the biopharmaceutical compMay 2, 2024 | marketbeat.comLos Angeles Capital Management LLC Buys 424,934 Shares of Incyte Co. (NASDAQ:INCY)Los Angeles Capital Management LLC boosted its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 37.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,570,296 shares of the biopharmaceutical company's stoMay 2, 2024 | businesswire.comIncyte to Present at Upcoming Investor ConferenceMay 1, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Hold Rating on Incyte (INCY)May 1, 2024 | marketbeat.comTD Cowen Cuts Incyte (NASDAQ:INCY) Price Target to $80.00TD Cowen dropped their target price on shares of Incyte from $88.00 to $80.00 and set a "buy" rating on the stock in a report on Wednesday.May 1, 2024 | marketbeat.comIncyte (NASDAQ:INCY) Earns Buy Rating from Truist FinancialTruist Financial reiterated a "buy" rating and set a $83.00 price target (down previously from $84.00) on shares of Incyte in a research report on Wednesday. Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street Legend Warns: "A Strange Day Is Coming to America" (Ad)Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making. Click here to learn more. INCY Media Mentions By Week INCY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼0.620.89▲Average Medical News Sentiment INCY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼158▲INCY Articles Average Week Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Medpace News Today Charles River Laboratories International News Today Exelixis News Today National Research News Today ICON Public News Today IQVIA News Today Insulet News Today Bio-Techne News Today Tenet Healthcare News Today Viatris News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.